Delaware’s Verisk ruling makes activist breakups harder: specific performance beats “we’ll just walk away” in the $2.35B AccuLynx case

A Delaware Chancery Court judge directed Verisk Analytics to try to proceed with its planned acquisition of AccuLynx for $2.35B in cash, after finding Verisk’s termination attempt was contractually invalid. The court did not stop at a money award; it granted specific performance (plus direct-cost damages), with performance framed around obtaining regulatory clearance (including FTC/HSR-related steps).

On the commercial side, the original deal announcement already described a $2.35B cash purchase, funded with fully committed debt financing and cash on hand, and expected to close by the end of Q3 2025 subject to customary conditions and regulatory approval. That structure matters legally because it turns “walk-away” into a contract-enforcement question: the court effectively held that the contract choice could not be undone by a termination narrative the court found internally caused.

In practical capital-markets terms, specific performance is the blunt instrument activists and holdouts fear most when the target wants the deal. Here, the court’s remedy package (specific performance + direct costs) follows from a clean legal chain: the court found Verisk’s termination was contractually invalid under Section 9.1 due to Verisk-caused failure of a closing condition. When that predicate is accepted by a Delaware judge, the activist/holdout playbook shifts from “delay the deal until economics change” toward “you may still lose the right to stop performance.”

Verisk Analytics is already a high-margin, cash-generating analytics platform. Using the listed-company fundamentals pulled in this session, Verisk reported revenue of $2.88B (FY 2024) and $3.07B (FY 2025), while operating cash flow was $1.14B (FY 2024) and $1.44B (FY 2025). That matters for M&A disputes because the “time-to-close” risk is less existential when the core franchise continues producing operating cash.

Cash deals are often marketed as speed and certainty—but the legal tail matters. Delaware’s posture here aligns with a simple investor takeaway: when the merger agreement’s termination logic is tethered to closing-condition failure and the court attributes causation to the acquirer’s conduct, the remedy can become “keep going, plus pay the direct costs.” That combination raises the expected cost of activist holdouts trying to engineer a termination outcome.